The Selection and Use of Essential Medicines: Report of the WHO Expert Committee, 2005 (including the 14th Model List of Essential Medicines).This report presents the recommendations of the WHO Expert Committee responsible for updating the WHO Model List of Essential Medicines. The first part provides a brief description of the Open Session of the Committee followed by updates on the Model Formulary and the Essential Medicines Library the Priority Medicines Project and current activities in the field of rational use. There are also progress reports on the review of essential medicines for reproductive health and of the New Emergency Health Kit. The second part presents summaries of the Committee's considerations and justifications for the various deletions additions and changes to the Model List. Annexes to the main report include the 14th WHO Model List of Essential Medicines and a list of all items on the Model List sorted according to their 5-level Anatomical Therapeutic Chemical (ATC) classification codes. |
Common terms and phrases
1-ml ampoule acid agents alcuronium ampoule ampoule injection ampoule tablet Annex antibacterials application ATC code Biological Standardization buprenorphine calcium capsule or tablet cefixime cilastatin Cochrane Database Cochrane review Committee also noted Committee noted Committee on Biological Committee recommended Complementary list contraceptives Database of Systematic derivatives diarrhoea drug effective efficacy and safety Emtricitabine essential medicines evidence Expert Committee Explanatory notes footnote on future Geneva group/medicine or item Health and Research immunoglobulin inhibitors ISDB isoniazid List of Essential Médecins Sans Frontières Medical medicines continued meeting in 2003 mg hydrochloride mg injection mg tablet mg/5 ml mg/ml in 5-ml micrograms mifepristone miltefosine misoprostol model formulary Model List niclosamide nifedipine oral solution oxamniquine pharmaceutical class possible fast-track deletion powder for injection praziquantel programmes Recommended example Reproductive Health reviewed for possible sodium salt spectinomycin square box sulfate Systematic Reviews Technical Report Series tenofovir therapeutic thioacetazone treatment triclabendazole Vaccine vial powder World Health Organization
Popular passages
Page 54 - Essential medicines are those that satisfy the priority health care needs of the population. They are selected with due regard to public health relevance, evidence on efficacy and safety, and comparative cost-effectiveness. Essential medicines are intended to be available within the context of functioning health systems at all times in adequate amounts, in the appropriate dosage forms, with assured quality and adequate information, and at a price the individual and the community can afford.
Page 84 - All plasma fractions should comply with the WHO Requirements for the Collection, Processing and Quality Control of Blood. Blood Components, and Plasma Derivatives (Revised 1992).
Page 52 - O'Brien, CP, Druley, P., Navaline, H., DePhilippis, D., Stolley, P. & Abrutyn, E. (1993) Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndrome, 6, 1049-1056.
Page 50 - Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2000;2:CD000567.
Page 52 - Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: Pooled analysis of randomized controlled trials, American Journal of Clinical Nutrition 72 (2000): 1516-1522; RB Costello and).
Page 51 - Lesko SM, Mitchell AA. The safety of acetaminophen and ibuprofen among children younger than two years old. Pediatrics 1999; 104:1-5.
Page 53 - Magee LA, Duley L. Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev.
Page 75 - The medicines are included in the relevant sections of the Model List, according to their therapeutic use, eg as analgesics.
Page 91 - World Health Organization. Cancer Pain Relief: With a Guide to Opioid Availability. 2nd ed. Geneva: World Health Organization, 1996.
Page 52 - Hofmeyr GJ, Gulmezoglu AM. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews 2002, (4):CD000941 (http://www.cochrane.org/cochrane/revabstr/AB000941.htm, accessed 13 February 2005).